Patients presenting with AF have a high risk of stroke due to blood stasis in the atria. Appropriately managing patients with AF with rate and/or rhythm control, along with proper anticoagulation can greatly reduce their risk of thromboembolic events.
With a selection of anticoagulants available, choosing which is most appropriate is based on patient preference and desired outcomes.
This workshop will guide pharmacists through the acute and ongoing management of AF, and stroke risk reduction with warfarin and NOACs.
After participating in this workshop, pharmacists should be able to:
- Describe the classifications of atrial fibrillation
- Discuss AF as a risk factor for thromboembolic events, and determine risk using CHA2DS2-VA scoring system
- Describe non-pharmacological and pharmacological cardioversion interventions in AF where spontaneous cardioversion does not occur
- Explain the place of rate and rhythm control in persistent and permanent AF
- Discuss anticoagulation in AF, notably the use of warfarin and NOACs to reduce stroke risk
- Discuss methods of reversal in emergency situations, as well as the process for ceasing and restarting anticoagulation peri-operatively
- Describe the process of transitioning patients from warfarin to NOACs
Group 1: 0.00 Credits
Group 2: 4.00 Credits
This activity has been accredited for 2 hours of Group 2 CPD (or 4 CPD credits) suitable for inclusion in an individual pharmacist’s CPD plan.
No attachments found